KeraLink International implements 3-prong approach to eliminate corneal blindness
Click Here to Manage Email Alerts
The nonprofit organization KeraLink International has announced three new initiatives to eradicate corneal blindness in low- and middle-income countries.
According to a KeraLink press release, the organization will focus on supporting the development of an innovative approach to corneal regeneration, advancing strategies to prevent and treat corneal conditions that can lead to blindness, and leading a global effort to combat infectious keratitis, the primary cause of corneal blindness worldwide.
“KeraLink International is unique in our singular focus on bringing health care providers, technology innovators, philanthropists and investors into a coordinated, collaborative effort to eliminate corneal blindness in [low- and middle-income countries],” Douglas J. Furlong, KeraLink’s board chairman, said in the release.
While untreated corneal blindness is uncommon in the U.S., 12.7 million children and adults experience corneal blindness in low- and middle-income countries that do not have access to quality eye care, the release stated. By implementing its “PEN” approach — preventing injuries and infections, early detection and rapid treatment, and novel therapies, such as corneal regeneration, at affordable prices — KeraLink International aims to eradicate corneal blindness in these underserved areas.
“Every case of corneal blindness prevented holds significant potential for positive social impact,” David Green, KeraLink’s president and CEO, said in the release.